ES2038135T3 - Medios para la administracion de acido hialuronico en mamiferos. - Google Patents
Medios para la administracion de acido hialuronico en mamiferos.Info
- Publication number
- ES2038135T3 ES2038135T3 ES87105907T ES87105907T ES2038135T3 ES 2038135 T3 ES2038135 T3 ES 2038135T3 ES 87105907 T ES87105907 T ES 87105907T ES 87105907 T ES87105907 T ES 87105907T ES 2038135 T3 ES2038135 T3 ES 2038135T3
- Authority
- ES
- Spain
- Prior art keywords
- hyaluronic acid
- tissue
- traumatized tissue
- mammals
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Abstract
LA PRESENTE PATENTE TRATA DEL INFORME DE QUE EL ACIDO HIALURONICO, UN CONOCIDO MEDIO PARA EVITAR LAS SECUELAS DEL TRAUMA EN TEJIDOS DE ARTICULACIONES DE ASPIRADORES POR SUMINISTRO DIRECTO EN EL TEJIDO TRAUMATIZADO, PARA UN TEJIDO TAL TRAUMATIZADO SE TRANSPORTA MEDIANTE EL PROCESO NATURAL DEL ASPIRADOR SI SE APLICA EN UN LUGAR ALEJADO DEL TEJIDO TRAUMATIZADO. ASI PUEDE LLEVARSE EL ACIDO HIALURONICO EN CADA FORMA ACEPTABLE TERAPEUTICAMENTE, MEDIANTE EL CAMINO TIPICO DE APLICACION DISTANTE EN PRACTICA, INCLUIDO APLICACION INTRAVENOSA, INTRAMUSCULAR, SUBCUTANEA O TOPICA. ESTO HACE LA APLICACION DEL ACIDO HIALURONICO MAS FACIL Y ATRACTIVA. POR EJEMPLO SE CONSIGUE EL TRATAMIENTO DE ARTRITIS EN ARTICULACIONES DE CABALLOS Y DE HOMBRES NO MAS DIFICILES INYECCIONES INTRA-ARTICULARES A TOMAR.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/856,732 US4808576A (en) | 1986-04-28 | 1986-04-28 | Remote administration of hyaluronic acid to mammals |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2038135T3 true ES2038135T3 (es) | 1996-07-16 |
Family
ID=25324378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87105907T Expired - Lifetime ES2038135T3 (es) | 1986-04-28 | 1987-04-22 | Medios para la administracion de acido hialuronico en mamiferos. |
Country Status (13)
Country | Link |
---|---|
US (1) | US4808576A (es) |
EP (1) | EP0243867B1 (es) |
JP (1) | JP2567393B2 (es) |
KR (1) | KR950007233B1 (es) |
AT (1) | ATE61523T1 (es) |
AU (1) | AU596838B2 (es) |
CA (1) | CA1314218C (es) |
DE (1) | DE3768546D1 (es) |
DK (1) | DK212587A (es) |
ES (1) | ES2038135T3 (es) |
HU (1) | HUT43790A (es) |
NZ (1) | NZ220098A (es) |
ZA (1) | ZA872964B (es) |
Families Citing this family (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5468737A (en) * | 1982-05-07 | 1995-11-21 | Carrington Laboratories, Inc. | Wound healing accelerated by systemic administration of polysaccharide from aloe |
US5080893A (en) * | 1988-05-31 | 1992-01-14 | University Of Florida | Method for preventing surgical adhesions using a dilute solution of polymer |
US5140016A (en) * | 1988-05-31 | 1992-08-18 | University Of Florida | Method and composition for preventing surgical adhesions using a dilute solution of polymer |
US6010692A (en) * | 1988-05-31 | 2000-01-04 | University Of Florida Research Foundation, Inc. | Method and composition for preventing surgical adhesions and tissue damage |
CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
US5095037B1 (en) * | 1989-12-21 | 1995-12-19 | Nissho Kk | Combined anti-inflammatory agent |
US5102783A (en) * | 1990-01-12 | 1992-04-07 | Vetrepharm, Inc. | Composition and method for culturing and freezing cells and tissues |
IT1240316B (it) * | 1990-02-21 | 1993-12-07 | Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C. | Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale |
US5910489A (en) * | 1990-09-18 | 1999-06-08 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US5824658A (en) * | 1990-09-18 | 1998-10-20 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US5639738A (en) * | 1992-02-20 | 1997-06-17 | Hyal Pharmaceutical Corporation | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
CA2061703C (en) * | 1992-02-20 | 2002-07-02 | Rudolf E. Falk | Formulations containing hyaluronic acid |
US5990096A (en) * | 1990-09-18 | 1999-11-23 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
AU652784B2 (en) * | 1990-10-18 | 1994-09-08 | Shiseido Company Ltd. | Combination of hyaluronic acid with medicinal ingredient and production thereof |
US5733891A (en) * | 1990-10-18 | 1998-03-31 | Shiseido Co., Ltd. | Compound for medicinal ingredient and hyaluronic acid and process for producing the same |
US5234914A (en) * | 1991-06-11 | 1993-08-10 | Patent Biopharmaceutics, Inc. | Methods of treating hemorrhoids and anorecial disease |
US5977088A (en) * | 1991-07-03 | 1999-11-02 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
WO1994007505A1 (en) * | 1991-07-03 | 1994-04-14 | Norpharmco Inc. | Use of hyaluronic acid and forms to prevent arterial restenosis |
US5834444A (en) * | 1991-07-03 | 1998-11-10 | Hyal Pharmaceutical Corporation | Hyaluronic acid and salts thereof inhibit arterial restenosis |
US6022866A (en) * | 1991-07-03 | 2000-02-08 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
US5817644A (en) * | 1991-07-03 | 1998-10-06 | Hyal Pharmaceutical Corporation | Targeting of dosages of medicine and therapeutic agents |
US5990095A (en) * | 1991-07-03 | 1999-11-23 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
US5792753A (en) * | 1991-07-03 | 1998-08-11 | Hyal Pharmaceutical Corporation | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs |
US6103704A (en) * | 1991-07-03 | 2000-08-15 | Hyal Pharmaceutical Corporation | Therapeutic methods using hyaluronic acid |
JP3310994B2 (ja) * | 1991-07-03 | 2002-08-05 | 電気化学工業株式会社 | アレルギー治療剤 |
US6136793A (en) * | 1992-02-20 | 2000-10-24 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US6218373B1 (en) | 1992-02-20 | 2001-04-17 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
CA2061567C (en) * | 1992-02-20 | 1998-02-03 | Rudolf E. Falk | Use of hyaluronic acid to repair ischemia reperfusion damage |
US6114314A (en) * | 1992-02-21 | 2000-09-05 | Hyal Pharmaceutical Corp. | Formulations containing hyaluronic acid |
US5767106A (en) * | 1992-02-21 | 1998-06-16 | Hyal Pharmaceutical Corporation | Treatment of disease and conditions associated with macrophage infiltration |
US5888984A (en) * | 1994-05-12 | 1999-03-30 | Dermal Research Laboratories, Inc. | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
US6096728A (en) * | 1996-02-09 | 2000-08-01 | Amgen Inc. | Composition and method for treating inflammatory diseases |
US20050090662A1 (en) * | 1997-01-15 | 2005-04-28 | Beavers Ellington M. | Method of making free acids from polysaccharide salts |
US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
ES2278447T3 (es) * | 1998-06-05 | 2007-08-01 | Nutramax Laboratories, Inc. | El uso de agentes anabolicos, agentes anticatabolicos, agentes antioxidantes y analgesicos para la proteccion, tratamiento y reparacion de tejidos conectivos en humanos y animales. |
JP4607264B2 (ja) * | 1998-12-01 | 2011-01-05 | 生化学工業株式会社 | ヒアルロン酸を有効成分とする異所性石灰化抑制剤 |
ATE361082T1 (de) | 1999-02-01 | 2007-05-15 | Dermal Res Lab Inc | Pharmazeutische zusammensetzung aus komplexen kohlenhydraten deren anwendung |
CA2366897C (en) * | 1999-04-06 | 2009-11-17 | Andrew B. Onderdonk | Immunomodulatory compositions and methods of use thereof |
US7879824B2 (en) * | 2001-07-31 | 2011-02-01 | Dermal Research Laboratories, Inc. | Methods of preventing or treating diseases and conditions using complex carbohydrates |
AU8136801A (en) * | 2000-07-31 | 2002-02-13 | Dermal Res Lab Inc | Methods of preventing or treating diseases and conditions using complex carbohydrates |
DE10053053A1 (de) * | 2000-10-19 | 2002-05-16 | Knoell Hans Forschung Ev | Pharmazeutische Formulierungen zur Hemmung von entzündlichen Arthritiden |
DE10111165A1 (de) * | 2001-03-02 | 2002-10-10 | Knoell Hans Forschung Ev | Verwendung von Hyaluronsäure-Uroniden zur Behandlung von entzündlichen Vorgängen |
US7635489B2 (en) * | 2001-05-18 | 2009-12-22 | Leneau Holdings, Llc | Ingestion of hyaluronic acid for improved joint health |
US6607745B2 (en) | 2001-05-18 | 2003-08-19 | Harry Leneau | Ingestion of hyaluronic acid for improved joint function and health |
US6528076B2 (en) | 2001-07-06 | 2003-03-04 | Magic Herb Corp. | Topical compositions and methods for treating pain |
KR20030026384A (ko) * | 2001-09-12 | 2003-04-03 | 정옥조 | 당뇨병 환자용 건강식품의 제조방법 및 그 제품 |
WO2003070256A1 (en) * | 2002-02-15 | 2003-08-28 | Research Development Foundation | Hyaluronic acid mediated adenoviral transduction |
JP2005530768A (ja) * | 2002-05-09 | 2005-10-13 | メディジーンズ | 血漿または血清を含有した創傷治療用医薬組成物 |
JP2004135177A (ja) * | 2002-10-11 | 2004-04-30 | Sharp Corp | 携帯電話機 |
US7504387B2 (en) * | 2002-10-16 | 2009-03-17 | Arthrodynamic Technologies, Animal Health Division, Inc. | Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis |
ATE525076T1 (de) | 2002-10-16 | 2011-10-15 | Arthrodynamic Technologies Animal Health Division Inc | Behandlung von traumatischer synovitis und geschädigtem gelenkknorpel |
US8455458B2 (en) * | 2002-10-16 | 2013-06-04 | Arthrodynamic Technologies, Animal Health Division, Inc. | Composition and method for treating connective tissue damage |
US7485629B2 (en) * | 2002-10-16 | 2009-02-03 | Arthrodynamic Technologies, Animal Health Division, Inc. | Composition and method for treatment of joint damage |
US20080003258A1 (en) * | 2002-10-16 | 2008-01-03 | Marcum Frank D | Composition and Method for Treating Rheumatoid Arthritis |
US7803787B2 (en) * | 2002-10-16 | 2010-09-28 | Arthrodynamic Technologies, Animal Health Division, Inc. | Composition and method for treating connective tissue damage by transmucosal administration |
WO2005032562A1 (en) * | 2003-10-09 | 2005-04-14 | Robert John Petrella | Methods for treating acute and overuse sprain and strain using hyaluronic acid |
GB0411165D0 (en) * | 2004-05-19 | 2004-06-23 | Bionovate Ltd | Hyaluronic acid containing pharmaceutical or veterinary compounds |
CA2475762A1 (en) * | 2004-07-27 | 2006-01-27 | Rycor Technology Investments Corp. | Dose dependent elimination of ha and cell receptor stimulation |
HUE025255T2 (en) * | 2004-12-30 | 2016-03-29 | Genzyme Corp | Intraarticular viscosity implementation schemes |
US7323184B2 (en) * | 2005-08-22 | 2008-01-29 | Healagenics, Inc. | Compositions and methods for the treatment of wounds and the reduction of scar formation |
US9492381B1 (en) | 2005-11-10 | 2016-11-15 | Reyn Pharma, Llc | Method of administering hyaluronan formulation for preventing and ameliorating osteoarthritis |
US8598144B1 (en) | 2005-11-10 | 2013-12-03 | Reyn Pharma, Llc | Method of administering hyaluronan formulation for the amelioration of osteoarthritis |
WO2007070617A1 (en) | 2005-12-14 | 2007-06-21 | Anika Therapeutics, Inc. | Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects |
EP1968614A2 (en) * | 2005-12-14 | 2008-09-17 | Anika Therapeutics Inc. | Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid |
US20080102107A1 (en) * | 2005-12-16 | 2008-05-01 | Valex Pharmaceuticals, Llc | Compositions and methods for transdermal joint pain therapy |
CN101522164B (zh) * | 2006-09-13 | 2014-03-26 | 提升肤质产品公司 | 用于治疗皮肤的化妆品组合物及其方法 |
AU2008210557B2 (en) | 2007-01-30 | 2013-08-01 | Cypress Pharmaceutical, Inc. | Hyaluronate compositions |
US9186375B2 (en) | 2007-06-21 | 2015-11-17 | Arthrodynamic Technologies, Animal Health Division, Inc. | Glycosaminoglycan compositions in combination with stem cells |
US8178511B1 (en) * | 2008-07-02 | 2012-05-15 | Smith James D | Method of administering hyaluronan formulation for the amelioration of osteopenia |
CA2739243C (en) | 2008-10-02 | 2017-08-22 | L.R.R.& D. Ltd. | Wound dressing comprising polymeric foam matrix and a hydrophilic polysaccharide disposed therein |
EP2886104A1 (en) | 2013-12-11 | 2015-06-24 | Patir, Suleyman | An intra-articular gel |
KR102588734B1 (ko) * | 2021-07-15 | 2023-10-13 | 최문석 | 짬뽕 감자 제조방법 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4055660A (en) * | 1974-06-26 | 1977-10-25 | Meierhenry Dwight W | Treatment for warts |
US4141973A (en) * | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
GB1523965A (en) * | 1976-03-19 | 1978-09-06 | Ici Ltd | Pharmaceutical compositions containing steroids |
US4296104A (en) * | 1979-08-30 | 1981-10-20 | Herschler R J | Therapeutic dimethyl sulfoxide composition and methods of use |
US4272522A (en) * | 1979-10-15 | 1981-06-09 | Balazs Endre A | Method for stimulating phagocytic activity and synergistic compositions therefor |
JPS56164120A (en) * | 1980-05-22 | 1981-12-17 | Chisso Corp | Antitumor agent |
IT1212892B (it) * | 1983-10-11 | 1989-11-30 | Della Valle Francesco | Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica |
US4517295A (en) * | 1983-02-18 | 1985-05-14 | Diagnostic, Inc. | Hyaluronic acid from bacterial culture |
NO161573C (no) | 1983-11-25 | 1989-08-30 | Miles Inc | Fremgangsmaate til fremstilling av hyaluronsyre. |
NO160722C (no) * | 1983-11-25 | 1989-05-24 | Miles Inc | Fremgangsmaate for fremstilling av ultraren hyaluronsyre. |
US4716224A (en) * | 1984-05-04 | 1987-12-29 | Seikagaku Kogyo Co. Ltd. | Crosslinked hyaluronic acid and its use |
JPS6120034A (ja) * | 1984-07-06 | 1986-01-28 | Konishiroku Photo Ind Co Ltd | 写真乳剤の保管方法 |
SE8501723L (sv) * | 1985-04-09 | 1986-10-10 | Pharmacia Ab | Preparation att anvendas vid behandling av ledinflammation |
GB8509301D0 (en) * | 1985-04-11 | 1985-05-15 | Clinical Products Dev Ltd | Device for surgical procedures |
-
1986
- 1986-04-28 US US06/856,732 patent/US4808576A/en not_active Expired - Lifetime
-
1987
- 1987-03-31 CA CA000533391A patent/CA1314218C/en not_active Expired - Lifetime
- 1987-04-15 AU AU71782/87A patent/AU596838B2/en not_active Expired
- 1987-04-22 AT AT87105907T patent/ATE61523T1/de not_active IP Right Cessation
- 1987-04-22 ES ES87105907T patent/ES2038135T3/es not_active Expired - Lifetime
- 1987-04-22 EP EP87105907A patent/EP0243867B1/de not_active Expired - Lifetime
- 1987-04-22 DE DE8787105907T patent/DE3768546D1/de not_active Expired - Lifetime
- 1987-04-27 NZ NZ220098A patent/NZ220098A/en unknown
- 1987-04-27 HU HU871850A patent/HUT43790A/hu unknown
- 1987-04-27 DK DK212587A patent/DK212587A/da not_active Application Discontinuation
- 1987-04-27 JP JP62102113A patent/JP2567393B2/ja not_active Expired - Fee Related
- 1987-04-27 ZA ZA872964A patent/ZA872964B/xx unknown
- 1987-07-01 KR KR1019870006850A patent/KR950007233B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA1314218C (en) | 1993-03-09 |
KR950007233B1 (ko) | 1995-07-07 |
KR890001572A (ko) | 1989-03-27 |
AU7178287A (en) | 1987-10-29 |
ATE61523T1 (de) | 1991-03-15 |
DE3768546D1 (de) | 1991-04-18 |
JPS62255428A (ja) | 1987-11-07 |
EP0243867A2 (de) | 1987-11-04 |
JP2567393B2 (ja) | 1996-12-25 |
DK212587D0 (da) | 1987-04-27 |
DK212587A (da) | 1987-10-29 |
HUT43790A (en) | 1987-12-28 |
AU596838B2 (en) | 1990-05-17 |
EP0243867B1 (de) | 1991-03-13 |
US4808576A (en) | 1989-02-28 |
NZ220098A (en) | 1991-06-25 |
EP0243867A3 (en) | 1988-03-23 |
ZA872964B (en) | 1987-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2038135T3 (es) | Medios para la administracion de acido hialuronico en mamiferos. | |
DE68910159D1 (de) | Dosierform für Verabreichung in der Humanmedizin. | |
ES2059965T3 (es) | Un procedimiento para preparar una composicion farmaceutica para el tratamiento de enfermedades inflamatorias. | |
MX9203543A (es) | Medicamento. | |
MX9204861A (es) | Analogos de polipeptidos que tienen actividad liberadora de la hormona de crecimiento. | |
ES2032009T3 (es) | Procedimiento para preparar complejos estables de interferon. | |
KR950702120A (ko) | 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis) | |
ES2187646T3 (es) | Procedimientos para el tratamiento de inflamaciones y composiciones correspondientes. | |
ATE170076T1 (de) | Angiotensin ii-antagonisten zur behandlung von viralen erkrankungen | |
DE69111974D1 (de) | Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum. | |
ATE111354T1 (de) | 2,3-dihydroergoline zur steigerung serotonerger funktionen. | |
KR910015300A (ko) | 부스피론 : 수면 무호흡증의 치료용도 | |
DK0669832T3 (da) | Fremgangsmåde til behandling eller forebyggelse af fedme | |
HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására | |
ATE130194T1 (de) | Subkutane verabreichung des humanen choriongonadotropins. | |
DK0652767T3 (da) | Behandling af manglende mælkedannelse hos mennesker | |
ES2012578A6 (es) | Procedimiento para preparar la sal de trometamina de 1-metil-beta-oxo-alfa- (fenilcarbamoil)-2-pirrolpropiontrilo. | |
SE8804640D0 (sv) | Medicament comprising cyclolinopeptide a | |
GB2260702B (en) | Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X | |
FI863192A0 (fi) | Preparat foer intramuskulaer injektering av mediciner, vitaminer eller vaccin. | |
HK139796A (en) | Use of stomatostatin in the manufacture of a medicament for the treatment of rheumatoid arthritis | |
DE69315840D1 (de) | Verfahren zur verabreichung einer lösung von granulozyten-kolonie-stimulierendem faktor | |
EP0282690A3 (en) | Treatment of rheumatoid arthritis with 3,5-dichloromethotrexate | |
ES2069990T3 (es) | Acido acilaminoalquilidenhidroxibisfosfonico util en la terapia de enfermedades osteoarticulares. | |
FR2791894B1 (fr) | Utilisation d'interferon beta dans le traitement de la tumeur d'ewing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 243867 Country of ref document: ES |
|
FG2A | Definitive protection |
Ref document number: 0243867 Country of ref document: ES |